TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
CommunityDashboard
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·July 15, 2026

Elevance Health Inc. (ELV) falls despite earnings beats

Elevance Health Inc. (ELV) falls 10.0% even after earnings beats, as investors react to the latest results and outlook.

Earnings FlashELVHealthcareMedical - Healthcare Plans
By TickerSpark·July 15, 2026·2 min read
Elevance Health Inc. (ELV) falls despite earnings beats
▌Key Takeaway
Elevance Health Inc. (ELV) posted a solid Q2 earnings beat, with EPS of $7.45 on revenue of $49.83 billion, topping estimates on both lines. Even so, the stock fell 10.02% in regular-session trading, signaling investors were not convinced the results were strong enough to sustain momentum in the managed-care name.

Elevance Health Inc. (ELV) beat on both profit and revenue, posting Q2 EPS of $7.45 on $49.83B in revenue versus estimates of $6.21 and $48.84B, but the stock still fell 10.02% in regular-session trading to $384.01.

Key Numbers

  • EPS: $7.45 vs $6.21 estimate, a clear beat.
  • Revenue: $49.83B vs $48.84B estimate, also a beat.
  • Stock reaction: ELV closed at $384.01, down 10.02% in regular-session trading from $426.79.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

  • Intraday range: shares traded between $376.16 and $395.86.
  • Beat streak: ELV has topped EPS estimates in 4 of the last 5 quarters, including $12.58 vs $10.82 in April and $3.33 vs $3.10 in January.

    • A beat on paper, but the market wanted more

    The raw numbers were strong. Elevance delivered an EPS beat of more than $1 and topped revenue estimates by nearly $1B. That extends a recent pattern of solid execution, with beats in four of the last five quarters.

    The problem is the stock move. A 10.02% drop in regular-session trading says investors were not impressed by the headline beat alone. In plain English, this was one of those quarters where good results did not translate into a good stock reaction.

    That disconnect matters. ELV came into the day as an $83.4B managed-care name, and a double beat would usually support the shares. Instead, the market marked the stock down hard, which puts more weight on whether this quarter was strong enough to change the recent tone around the name.

    Bottom line

    Elevance Health Inc. (ELV) delivered a clean earnings beat, but a 10.02% regular-session selloff shows investors wanted stronger proof that the momentum can hold.

    Read the full ELV research report
    ▌Common Questions

    Frequently asked questions

    +Why did Elevance Health stock fall after beating earnings?
    Elevance Health Inc. (ELV) beat Q2 EPS estimates by more than $1 and revenue estimates by nearly $1 billion, but the stock still dropped 10.02% in regular-session trading to $384.01. The market reaction suggests investors wanted stronger forward momentum or more convincing guidance than the headline beat alone.
    +What were Elevance Health's Q2 earnings and revenue results?
    Elevance Health reported Q2 EPS of $7.45 versus the $6.21 estimate. Revenue came in at $49.83 billion, above the $48.84 billion consensus estimate.
    +Did Elevance Health beat earnings estimates this quarter?
    Yes, Elevance Health Inc. (ELV) beat both profit and revenue expectations in Q2. It has now topped EPS estimates in 4 of the last 5 quarters, including prior beats of $12.58 versus $10.82 in April and $3.33 versus $3.10 in January.
    +How much did ELV stock move after the earnings report?
    ELV closed at $384.01, down 10.02% in regular-session trading from $426.79. During the session, shares traded between $376.16 and $395.86.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on ELV?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the ELV report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full ELV research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the ELV report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on ELV

    More to read

    All articles
    Elevance beat and raised, so why did the stock trade like something broke?
    ELV

    Elevance beat and raised, so why did the stock trade like something broke?

    Elevance didn't get punished for missing the quarter; it got punished because the market no longer trusts the quality of the beat. Raised guidance matters less when Medicaid costs are still rising, membership is slipping, and management is calling 2026 the low point for profitability.

    Jul 16·4 min
    Elevance Health (ELV): Margin Repair and Earnings Recovery
    ELV

    Elevance Health (ELV): Margin Repair and Earnings Recovery

    Elevance Health is working through a Medicaid-driven margin reset, but Q2 results, raised guidance, and Carelon growth point to a resilient earnings recovery. The stock looks attractively valued for a large managed-care platform with scale, cash flow, and multiple growth levers.

    Jul 16·22 min
    Elevance Health Inc. (ELV) drops on deep earnings analysis
    ELV

    Elevance Health Inc. (ELV) drops on deep earnings analysis

    Elevance Health beat EPS and revenue, but the stock drops as investors focus on Medicaid margin pressure, membership declines, and the quality of the upside. This deep-dive breaks down the quarter’s mix, guidance, Carelon integration, and why a clean beat still failed to win the market.

    Jul 15·10 min